Novel Intervention Relieves Depression in MS Patients
An internet-based approach for providing cognitive-behavioral therapy reduces depressive symptoms, which are common in patients with multiple sclerosis.
Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An internet-based approach for providing cognitive-behavioral therapy reduces depressive symptoms, which are common in patients with multiple sclerosis.
Breastfeeding by women with MS or NMSOD who are taking anti-CD20 IgG1 monoclonal antibodies appears to be safe for infants, new research suggests.
Nondisabling relapses within 2 years of a multiple sclerosis diagnosis is linked to disability accumulation, and supports early use of high-efficacy, disease-modifying therapies, new research suggests.
New data from SPRINT-MS show that the drug has beneficial effects on slowly evolving lesions in people with multiple sclerosis, perhaps by abrogating chronic active lesions.
Although serum glial fibrillary acid protein (GFAP) could be a useful complement to the multiple sclerosis biomarker neurofilament light chain (NfL), it is not ready for the clinic, experts say.